This new stent, which will mechanically open the esophagus, also will release the anti-cancer drug paclitaxel (PTX) to locally
treat esophageal cancer.
Better therapies to
treat esophageal cancer are badly needed.
Our oncologists have many years of experience researching and
treating esophageal cancer, and are actively conducting clinical trials of promising new drugs to treat the disease.
Not exact matches
Between one and five people in every 100 with Barrett's esophagus go on to develop
esophageal cancer in their life - time, a form of
cancer that can be difficult to
treat, particularly if not caught early enough.
As of September 2014, 90 patients were disease - free, including 7 patients who had been
treated for recurrent
esophageal cancer during the first 5 years.
Patients are asked to take part in this research study because they have
esophageal and gastroesophageal junction
cancer treated with chemotherapy and radiotherapy followed by surgery (resected), but still have residual disease in resected tissue.
The gold standard for
treating inoperable
esophageal cancer patients is a surgically implanted metal mesh stent, which causes a number of complications such as bleeding, chest pain, perforation, and tumor ingrowth.
Currently, the CDK9 inhibitor flavopiridol is being evaluated in several phase I and II clinical trials for its anti-
cancer effects either as a single agent or in combination with other drugs in treatment of
esophageal cancer, B - cell chronic lymphocytic leukemia, endometrial carcinoma, recurrent / metastatic squamous cell carcinoma and most relevantly, previously
treated locally advanced or metastatic breast
cancer (http://www.cancernetwork.com/review-article/current-clinical-trials-flavopiridol/page/0/2).
Chronic, severe acid reflux can damage the esophagus if it's not
treated, and can even lead to a precancerous condition known as Barrett's esophagus, or
esophageal cancer.
ENTA has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and neck and
esophageal cancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and c
cancer and a partnership with the American
Cancer Society to educate and treat patients with smoking disorders and c
Cancer Society to educate and
treat patients with smoking disorders and
cancercancer.